Secondary avascular necrosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:399169
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Secondary avascular necrosis (also known as secondary osteonecrosis or secondary aseptic necrosis of bone) is a condition in which bone tissue dies due to a loss of blood supply, occurring as a consequence of an identifiable underlying cause or risk factor. Unlike primary (idiopathic) avascular necrosis, the secondary form is attributed to specific triggers such as prolonged corticosteroid use, excessive alcohol consumption, sickle cell disease, systemic lupus erythematosus, organ transplantation, radiation therapy, Gaucher disease, or other conditions that compromise vascular supply to bone. The femoral head (hip) is the most commonly affected site, though other bones such as the humeral head (shoulder), knee, and ankle can also be involved. The disease primarily affects the musculoskeletal system. Early stages may be asymptomatic, but as the condition progresses, patients typically experience increasing joint pain, stiffness, and reduced range of motion. Pain may initially occur only with weight-bearing activities but can progress to pain at rest. Without intervention, the affected bone may collapse, leading to secondary osteoarthritis and severe functional impairment. Diagnosis is typically made through imaging, with MRI being the most sensitive modality for early detection. Treatment depends on the stage of disease and the extent of bone involvement. Conservative approaches include pain management, protected weight-bearing, and addressing modifiable risk factors (such as reducing corticosteroid doses or alcohol cessation). Surgical options range from core decompression and bone grafting in early stages to total joint replacement in advanced cases with significant bone collapse. Pharmacological interventions such as bisphosphonates and anticoagulants have been investigated, though evidence for their efficacy remains limited. Early detection and intervention are critical to preserving joint function and delaying the need for joint replacement surgery.

Also known as:

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Secondary avascular necrosis.

View clinical trials →

No actively recruiting trials found for Secondary avascular necrosis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Secondary avascular necrosis community →

No specialists are currently listed for Secondary avascular necrosis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Secondary avascular necrosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Secondary avascular necrosisForum →

No community posts yet. Be the first to share your experience with Secondary avascular necrosis.

Start the conversation →

Latest news about Secondary avascular necrosis

No recent news articles for Secondary avascular necrosis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Secondary avascular necrosis

What is Secondary avascular necrosis?

Secondary avascular necrosis (also known as secondary osteonecrosis or secondary aseptic necrosis of bone) is a condition in which bone tissue dies due to a loss of blood supply, occurring as a consequence of an identifiable underlying cause or risk factor. Unlike primary (idiopathic) avascular necrosis, the secondary form is attributed to specific triggers such as prolonged corticosteroid use, excessive alcohol consumption, sickle cell disease, systemic lupus erythematosus, organ transplantation, radiation therapy, Gaucher disease, or other conditions that compromise vascular supply to bone.